相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trends in prescribing of sedative-hypnotic medications in the USA: 1993-2010
Christopher N. Kaufmann et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2016)
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
W. Joseph Herring et al.
BIOLOGICAL PSYCHIATRY (2016)
Cognitive Behavioral Therapy for Chronic Insomnia A Systematic Review and Meta-analysis
James M. Trauer et al.
ANNALS OF INTERNAL MEDICINE (2015)
Insomnia With Physiological Hyperarousal Is Associated With Hypertension
Yun Li et al.
HYPERTENSION (2015)
Effects of cognitive behavioural therapy for insomnia on the mental health of university students: study protocol for a randomized controlled trial
Daniel Freeman et al.
TRIALS (2015)
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore et al.
JAMA PSYCHIATRY (2015)
Quantitative Measures of Nocturnal Insomnia Symptoms Predict Greater Deficits Across Multiple Daytime Impairment Domains
Christopher L. Drake et al.
BEHAVIORAL SLEEP MEDICINE (2015)
Insomnia increases risk for cardiovascular events in women and in men with low socioeconomic status: A longitudinal, register-based study
Catarina Canivet et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2014)
Insomnia as a risk factor for ill health: results from the large population-based prospective HUNT Study in Norway
Borge Sivertsen et al.
JOURNAL OF SLEEP RESEARCH (2014)
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
David Michelson et al.
LANCET NEUROLOGY (2014)
The GoodNight study-online CBT for insomnia for the indicated prevention of depression: study protocol for a randomised controlled trial
John A. Gosling et al.
TRIALS (2014)
Benzodiazepine use and risk of dementia: prospective population based study
Sophie Billioti de Gage et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
The Medicalization of Sleeplessness: A Public Health Concern
Mairead Eastin Moloney et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2011)
Prevalence and Perceived Health Associated with Insomnia Based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition Criteria: Results from the America Insomnia Survey
Thomas Roth et al.
BIOLOGICAL PSYCHIATRY (2011)
Improved Insomnia Symptoms and Sleep-Related Next-Day Functioning in Patients With Comorbid Major Depressive Disorder and Insomnia Following Concomitant Zolpidem Extended-Release 12.5 mg and Escitalopram Treatment: A Randomized Controlled Trial
Maurizio Fava et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Eszopiclone for the Treatment of Posttraumatic Stress Disorder and Associated Insomnia: A Randomized, Double-Blind, Placebo-Controlled Trial
Mark H. Pollack et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Residual Symptoms in Depressed Outpatients Who Respond by 50% But Do Not Remit to Antidepressant Medication
Shawn M. McClintock et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial
Hadine Joffe et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
Characteristics of Individuals With Insomnia Who Seek Treatment in a Clinical Setting Versus Those Who Volunteer for a Randomized Controlled Trial
Judith R. Davidson et al.
Behavioral Sleep Medicine (2009)
Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference
Min Yang et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Zolpidem Extended-Release Improves Sleep and Next-Day Symptoms in Comorbid Insomnia and Generalized Anxiety Disorder
Maurizio Fava et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for US clinical practice
Andrew D. Krystal
SLEEP MEDICINE REVIEWS (2009)
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder
Mark Pollack et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Eszopiclone in patients with insomnia during perimenopause and early postmenopause - A randomized controlled trial
Claudio N. Soares et al.
OBSTETRICS AND GYNECOLOGY (2006)
Treating insomnia: Current and investigational pharmacological approaches
Bjarke Ebert et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder
M Fava et al.
BIOLOGICAL PSYCHIATRY (2006)
Self-report measures of insomnia in adults: rationales, choices, and needs
DE Moul et al.
SLEEP MEDICINE REVIEWS (2004)
Quantitative criteria for insomnia
KL Lichstein et al.
BEHAVIOUR RESEARCH AND THERAPY (2003)
Epidemiology of insomnia: what we know and what we still need to learn
MM Ohayon
SLEEP MEDICINE REVIEWS (2002)
Validation of the Insomnia Severity Index as an outcome measure for insomnia research
Celyne H. Bastien et al.
SLEEP MEDICINE (2001)
分享论文
